Zions Bancorporation, National Association’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.4K Buy
595
+121
+26% +$6.3K ﹤0.01% 641
2026
Q1
$22.7K Buy
474
+64
+16% +$2.8K ﹤0.01% 709
2025
Q4
$15.8K Buy
+410
New +$15.6K ﹤0.01% 767

Other funds holding RPRX

Zions Bancorporation, National Association's RPRX Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Royalty Pharma (RPRX) stake by 26% in Q2 2026, buying an estimated $6.3K and bringing the position to 595 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #641.

Zions Bancorporation, National Association first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Zions Bancorporation, National Association held 595 shares of Royalty Pharma worth $33.4K as of Q2 2026.
  • Zions Bancorporation, National Association bought 121 Royalty Pharma shares in Q2 2026, an estimated $6.3K.
  • Royalty Pharma made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #641 holding.
  • Zions Bancorporation, National Association first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.